Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
Myriad Genetics (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has announced its participation in two upcoming investor healthcare conferences. The company's management will be featured in fireside chats at:
- The Wells Fargo Healthcare Conference on Sept. 4, 2024, at 1:30pm ET, with CFO Scott Leffler
- The Morgan Stanley Healthcare Conference on Sept. 5, 2024, at 7:00am ET, with President and CEO Paul J. Diaz
Investors and interested parties can access live and archived webcasts of both presentations through the company's investor relations website at investor.myriad.com.
Myriad Genetics (NASDAQ: MYGN), leader nel test genetici e nella medicina di precisione, ha annunciato la sua partecipazione a due prossimi convegni per investitori nel settore sanitario. La dirigenza dell'azienda parteciperà a discussioni informali nei seguenti eventi:
- Il Wells Fargo Healthcare Conference il 4 settembre 2024, alle 13:30 ET, con il CFO Scott Leffler
- Il Morgan Stanley Healthcare Conference il 5 settembre 2024, alle 7:00 ET, con il Presidente e CEO Paul J. Diaz
Gli investitori e le parti interessate possono accedere a webcast dal vivo e registrati di entrambe le presentazioni attraverso il sito delle relazioni con gli investitori dell'azienda all'indirizzo investor.myriad.com.
Myriad Genetics (NASDAQ: MYGN), líder en pruebas genéticas y medicina de precisión, ha anunciado su participación en dos próximas conferencias de atención médica para inversores. La gestión de la empresa participará en charlas informales en:
- La Wells Fargo Healthcare Conference el 4 de septiembre de 2024, a la 1:30 p.m. ET, con el CFO Scott Leffler
- La Morgan Stanley Healthcare Conference el 5 de septiembre de 2024, a las 7:00 a.m. ET, con el Presidente y CEO Paul J. Diaz
Los inversores y partes interesadas pueden acceder a webcasts en vivo y grabados de ambas presentaciones a través del sitio web de relaciones con los inversores de la empresa en investor.myriad.com.
Myriad Genetics (NASDAQ: MYGN), 유전자 검사 및 정밀 의학 분야의 선두주자가, 두 개의 투자자 의료 회의에 참여할 예정이라고 발표했습니다. 회사의 경영진은 다음 행사에서 진행되는 일대일 대화에 참여할 것입니다:
- 웰스 파고 헬스케어 컨퍼런스가 2024년 9월 4일, 오후 1시 30분 ET에, CFO 스콧 레플러와 함께 진행됩니다.
- 모건 스탠리 헬스케어 컨퍼런스가 2024년 9월 5일, 오전 7시에, 회장 겸 CEO 폴 J. 디아즈와 함께 진행됩니다.
투자자와 이해관계자는 회사의 투자자 관계 웹사이트인 investor.myriad.com을 통해 두 프레젠테이션의 실시간 및 녹화된 웹캐스트에 접근할 수 있습니다.
Myriad Genetics (NASDAQ: MYGN), un leader dans le domaine des tests génétiques et de la médecine de précision, a annoncé sa participation à deux prochaines conférences de santé pour investisseurs. La direction de l'entreprise participera à des discussions informelles lors des événements suivants :
- La Wells Fargo Healthcare Conference le 4 septembre 2024 à 13h30 ET, avec le CFO Scott Leffler
- La Morgan Stanley Healthcare Conference le 5 septembre 2024 à 7h00 ET, avec le Président et CEO Paul J. Diaz
Les investisseurs et les parties intéressées peuvent accéder à des webcasts en direct et archivés des deux présentations via le site des relations avec les investisseurs de l'entreprise à l'adresse investor.myriad.com.
Myriad Genetics (NASDAQ: MYGN), ein führendes Unternehmen im Bereich genetische Tests und Präzisionsmedizin, hat seine Teilnahme an zwei bevorstehenden investor healthcare conferences bekannt gegeben. Das Management des Unternehmens wird in informellen Gesprächen bei folgenden Veranstaltungen vertreten sein:
- Der Wells Fargo Healthcare Conference am 4. September 2024 um 13:30 Uhr ET, mit CFO Scott Leffler
- Der Morgan Stanley Healthcare Conference am 5. September 2024 um 7:00 Uhr ET, mit Präsident und CEO Paul J. Diaz
Investoren und Interessierte können über die Investor-Relations-Website des Unternehmens unter investor.myriad.com auf live und archivierte Webcasts beider Präsentationen zugreifen.
- None.
- None.
SALT LAKE CITY, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Myriad management will participate in two upcoming investor healthcare conferences.
- The Wells Fargo Healthcare Conference in a fireside chat featuring Scott Leffler, Chief Financial Officer, on Sept. 4, 2024 at 1:30pm ET.
- The Morgan Stanley Healthcare Conference in a fireside chat featuring Paul J. Diaz, President and CEO, on Sept. 5, 2024 at 7:00am ET.
Links to the live and archived webcasts of both presentations can be viewed at investor.myriad.com.
About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com
Media Contact
Glenn Farrell
(385) 318-3718
PR@myriad.com
FAQ
When is Myriad Genetics (MYGN) participating in the Wells Fargo Healthcare Conference?
Who will represent Myriad Genetics (MYGN) at the Morgan Stanley Healthcare Conference?
How can investors access the webcasts of Myriad Genetics (MYGN) conference presentations?
What type of company is Myriad Genetics (MYGN)?
